First Affiliated Hospital Of Guangxi Medical University

This early-phase study tests a new treatment called CLL-1 CAR-T for children aged 3 to 18 with acute myeloid leukemia (AML) that has returned or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack leukemia cells. …

This study looks at whether making small punctures in the ovary during egg retrieval can improve egg count in women with diminished ovarian reserve (low egg supply). About 214 women undergoing IVF will be randomly assigned to get the punctures or standard care. The main goal is t…

This study tests a clot-dissolving drug called tenecteplase for people who have a stroke but don't know exactly when it started, like waking up with symptoms. About 352 participants will receive either tenecteplase or standard care after a simple CT scan. The goal is to see if th…

This study tests a new treatment plan for adults with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The treatment combines a special type of radiation with an immunotherapy drug and other supportive medicines. The goal is to see if this combination…

This study tests whether inhaling tiny particles from stem cells (called exosomes) can prevent or treat severe mouth sores caused by radiation therapy. About 200 head and neck cancer patients getting radiation will receive either the exosome mist or a placebo. The goal is to see …

This study tests a special AI (UroMed) designed for urology to see if it can safely help doctors. About 1080 patients with kidney stones, enlarged prostate, or bladder cancer will get either AI-assisted or traditional care. The goal is to check if the AI can provide accurate, saf…

This study looks at how well and how safely a clot-busting drug called tenecteplase works in people aged 80 and older who have had a stroke. Researchers will track recovery and side effects in 392 patients who receive the drug within 4.5 hours of symptoms. The goal is to gather r…